Preferred Stockholders Control Their Designated Board Seats
Wilson Sonsini partner Becki DeGraw argues that startup founders should treat board seats as durable allocations of corporate control, not as informal advisory roles they can revoke when a relationship sours. Boards approve consequential actions from financings and equity grants to CEO changes, and preferred-stock investors commonly gain designated seats whose holders are elected by their own class of stock. Once those rights are set in the charter and financing documents, common stockholders generally cannot remove the investor’s director without that investor’s agreement.
A startup board is not advisory by default
At an early-stage company, the board is not merely a group of experienced people available for advice. Becki DeGraw describes it as the body that “sets the strategic vision” and manages the company’s affairs at the highest level. Officers handle operations, but material corporate acts sit with directors.
That includes every issuance of securities, even a single share; option grants; financings through SAFEs, convertible notes, preferred stock, or bank debt; material contracts; mergers and acquisitions; and hiring or firing the CEO. A founder deciding whom to add is therefore making a governance decision, not assembling an informal panel of mentors.
The really important stuff, that's at the board level.
The practical implication is straightforward: founders should seek both alignment and useful judgment. Startups can pivot, DeGraw notes, but a director should share the company’s present direction and offer genuine perspective on where it could go. The founder also needs to like working with that person. Board membership creates a durable relationship around consequential decisions, especially once a company’s capital structure becomes more complicated.
Jason Calacanis offers a practical rule of thumb: a company may benefit from more formal governance once the amount it has raised plus the amount it is generating approaches $2 million or $3 million. He does not argue that a pre-product-market-fit startup needs a full board calendar. Rather, he sees value in beginning the discipline early: a small board, a few meetings, board decks, and written resolutions can make the company more organized before a Series A investor arrives.
DeGraw’s legal point is that the work exists whether or not there is a meeting. A company may approve option grants by written consent rather than convening directors, but that remains a board action. At a meeting, a majority can approve an action. By written consent, every director must sign for the action to be valid. Adding unnecessary directors early therefore means adding more people whose agreement may be required.
Control typically shifts with the priced round, not the SAFE
Jason Calacanis draws a distinction between early convertible financing and the point at which an investor has enough ownership to seek formal oversight. SAFEs and convertible notes often represent relatively small positions: investors may own basis points or low single-digit percentages and generally neither need nor want a board seat. When an investor is acquiring something closer to 10%, 15%, or 20% of the company, he says, the request becomes more common.
DeGraw agrees with the direction of that rule, while locating the usual legal transition more specifically at the preferred-stock financing. The lead investor in a Seed or Series A priced round is writing a substantial check, wants visibility into how the company is run, and may have fiduciary obligations to the fund’s limited partners. That is when a preferred director commonly appears. A lead SAFE investor would not ordinarily receive the same request.
At that stage, however, founders commonly retain board control. The usual shape might be two common-director seats held by founders and one preferred-director seat held by the Series A investor. The board becomes “balanced” later, often around a Series B: two common directors, two preferred directors, and an independent director to break a potential tie.
The word independent should not be confused with a ritual label. Calacanis points to a familiar concern: an investor may propose someone characterized as independent who is, in practice, socially or professionally aligned with that investor. DeGraw says the more useful selection principle is to ask where the company needs help. A company trying to reach a particular set of customers or scale in a particular industry may benefit from a director with relevant access and expertise.
The governance documents often give each side a role. Common holders may have the right to designate the independent director, subject to acceptability by the preferred side or the board; the arrangement can work in reverse as well. Neither side necessarily gets to impose a sibling, friend, or closely affiliated nominee without the other side’s consent.
For a private-company independent director at this stage, DeGraw says cash is often not part of the package until very late, perhaps shortly before an IPO. Equity is more typical, commonly vesting monthly over two years. Her described reasonable range is roughly 0.5% to 1%, depending on the person and company. Calacanis separately offers 25 to 50 basis points as his practical reference point for a startup director grant. These are not a single market rate or a universal benchmark; they are two speakers’ ranges for compensation that may be somewhat larger than an advisor award.
Board members also commonly seek reimbursement for travel expenses, according to DeGraw. The company should apply its travel policy rather than treating the board seat as an entitlement to unrestricted travel. Venture firms vary in whether they seek reimbursement, but a request for a flight to attend a meeting is not, by itself, unusual.
An observer can have access without a vote
A board observer can be an important compromise between an investor’s desire for information and a founder’s desire to keep the voting board small. Becki DeGraw draws the line clearly: a director has a vote and fiduciary duties to the company; an observer has neither.
A director must make decisions in the interests of the company and its stockholders, even when the outcome is not favorable to the director’s fund or personal interests. Under an observer arrangement, an observer may be invited to attend meetings, receive board materials, and ask questions. Some are highly influential and may sway the direction in which directors vote. But the observer cannot vote on the matter.
That lack of fiduciary duty has a second consequence: confidentiality should not be left implicit. DeGraw’s advice is to put a board-observer provision or letter in place, because an observer is not a director and should be expressly bound to appropriate confidentiality and related terms before receiving company information.
Calacanis describes why he has sometimes preferred observer status even as an investor entitled to a board seat. An investor can send an associate or analyst to take notes and maintain visibility into the company’s health, direction, financing plans, and major corporate activity without adding another voting participant to the board.
For smaller investors, that access can matter when a company announces a financing only at the signature stage. Calacanis describes the pressure tactic: an investor receives a call saying the round is complete and is told to sign within 24 hours, with the implication that refusing makes them the obstacle. The investor may instead need time to read the documents and consult counsel—particularly if the deal materially changes the capitalization table.
In his view, observer status can reduce that informational asymmetry. It can provide earlier visibility into whether a company is profitable, running short of money, raising capital, or considering a sale. It may also let an investor offer relevant help before a process is effectively over, rather than learning only after a buyer or financing structure has been selected.
A preferred director’s seat is usually difficult to take away
The most consequential constraint comes after an investor receives a designated preferred-director seat. Founders frequently ask how to remove a difficult director after the relationship has deteriorated: someone may be pessimistic, abrasive, consistently unprepared, or simply no longer aligned with the company. Becki DeGraw says the answer is often unwelcome.
Directors are elected and removed by stockholders. In a venture-backed company, however, the board structure commonly assigns particular seats to particular classes or series of stock. The common stockholders elect the common-director seats. A Series A preferred seat is generally elected by the Series A preferred stockholders. Common stock—even super-voting common stock—does not vote for that preferred seat.
Unless they are willing to go and they agree to go, there's nothing you can do as a common holder to do it.
The practical force of those protections depends on the company’s charter, the financing documents, and the voting agreement that govern the seat. DeGraw says the preferred financing documents commonly reinforce the structure: a lead investor may negotiate a right to designate the director for as long as it retains a specified portion of the shares it bought, often 25% to 50%. A voting agreement can then require the company’s common and preferred stockholders to vote for that designee. Where those provisions are in place, common stockholders cannot simply use their own votes to replace the investor’s representative.
The big difference with marriage and preferred directors, in a marriage you can say, man, this is not working out, I'm out.
Unlike in that marriage analogy, DeGraw’s point is that a common holder cannot unilaterally leave the preferred-director relationship. The practical route is not a legal maneuver but a conversation. A director may agree to step down when the company has outgrown the relationship, when later-stage investors can offer more relevant support, when the early investor is out of capital, or when an oversized board needs to shrink. The investor still owns its stake and therefore has an interest in the company’s success. The appeal, she says, is to reach a shared view of what serves that interest.
Jason Calacanis advises founders to build the relationship before it is needed. Make time outside formal meetings: a walk, lunch, a visit with the management team, or a drive to the airport. Those interactions do not alter contractual designation rights, but they create enough trust to make difficult conversations possible.
He also argues that directors have a responsibility beyond criticism. Board members should be constructive in periods when the company is under pressure. A board can address serious problems without making the operating team leave every meeting feeling that they are being punished for having them.
For investors, Calacanis’s personal concession when founders no longer value his presence is to move to observer status rather than insist on remaining a voting director. That is voluntary, not a power founders can generally compel. The legal structure may give the preferred investor substantial control over its seat; the human relationship determines whether that control has to be exercised to its limit.